Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Digoxin × Clear all

NCT01162135 2025-05-04

Digoxin for Recurrent Prostate Cancer

Phase 2 Completed

16 enrolled 7 charts

Prostatic Neoplasms